1. A breast cancer gene classification for indolent disease. (March 2017) Authors: Delahaye, L.; Drukker, C.; Dreezen, C.; Witteveen, A.; Chan, B.; Snel, M.; Beumer, I.; Neijenhuis, S.; van "t Veer, L.; Glas, A. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BluePrint molecular subtyping recognizes single and dual subtype tumors with consequences for therapeutic guidance. (October 2020) Authors: Ellappalayam, A.; Kuilman, M.; Mittempergher, L.; Wehkamp, D.; Chan, B.; Bhaskaran, R.; Glas, A. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeting canonical WNT signaling in primary chondrocytes by small peptides. (April 2016) Authors: Held, A.; Glas, A.; Dietrich, L.; Grossmann, T.; Pap, T.; Bertrand, J. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeting β-catenin dependent Wnt signaling via peptidomimetic inhibitors in murine chondrocytes and OA cartilage. Issue 6 (June 2018) Authors: Held, A.; Glas, A.; Dietrich, L.; Bollmann, M.; Brandstädter, K.; Grossmann, T.N.; Lohmann, C.H.; Pap, T.; Bertrand, J. Journal: Osteoarthritis and cartilage Issue: Volume 26:Issue 6(2018) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗